{"id":"W2947158459","doi":"10.1200/jco.2019.37.15_suppl.4052","title":"The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Charles-Le Moyne; Western University; Cancer Care Ontario; Ottawa Regional Cancer Foundation; London Health Sciences Centre","funders":"","keywords":"Medicine; Epirubicin; Esophagus; Esophageal cancer; Radiation therapy; Clinical endpoint; Dysphagia; Internal medicine; Neoadjuvant therapy; Surgery; Chemotherapy; Randomized controlled trial; Chemoradiotherapy; Adverse effect; Quality of life (healthcare); Stage (stratigraphy); Gastroenterology; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00145536,0.0004843312,0.0009630284,0.0001476587,0.0002036484,0.0005650459,0.0003568184,0.000734695,0.004800894],"category_scores_gemma":[0.001356412,0.0002182518,0.001021921,0.0002451331,0.0004043007,0.0005978118,0.0003872874,0.001409366,0.0004572693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004053861,"about_ca_system_score_gemma":0.000632848,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000545788,"about_ca_topic_score_gemma":0.001428097,"domain_scores_codex":[0.9994546,0.0003584567,0.00003119925,0.00007179274,0.00003565847,0.00004829368],"domain_scores_gemma":[0.9995776,0.0001081724,0.0001377923,0.00002495614,0.00002142045,0.0001300612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9717248,0.002650908,0.004056428,0.000576549,0.0007084697,0.00004239717,0.00003473419,0.0005069413,0.001101504,0.0001465623,0.00113649,0.01731412],"study_design_scores_gemma":[0.862765,0.109846,0.02137797,0.0001364777,0.001043897,0.0001372768,0.00003656676,0.00117152,0.0004058421,0.000450389,0.002609952,0.00001897634],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878472,0.004822785,0.0004101324,0.001137007,0.0004000887,0.001280317,0.001606678,0.00003051674,0.002465351],"genre_scores_gemma":[0.9896311,0.001552976,0.0008266795,0.0009841003,0.0002759163,0.002337793,0.001788003,0.000009063068,0.002594292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004800894,"threshold_uncertainty_score":0.01606059,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2981304060792845,"score_gpt":0.572361625842314,"score_spread":0.2742312197630295,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}